Naturasil Mite B Gone (sulfur) NDC 10893-530

NDC codes

FDA NDC Directory

Product NDC (as listed)10893-530Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10893-0530Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
10893-530-04	10893053004	118.3 mL in 1 BOTTLE (10893-530-04)Marketed from Feb 1, 2024
10893-530-08	10893053008	1 BOTTLE in 1 BOX (10893-530-08) / 236.6 mL in 1 BOTTLEMarketed from Feb 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naturasil Mite B Gone
Generic name (nonproprietary): sulfur
Active ingredients: Sulfur — 1 [hp_X]/118.3mL
Dosage form: Lotion
Route: Topical
Labeler: Nature's Innovation, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Feb 1, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 10893-530_38dbb162-56a7-49ea-b6ec-2e5bb202462dSPL ID 38dbb162-56a7-49ea-b6ec-2e5bb202462dSPL set ID d15c2ac6-f323-41af-adfe-f4c88427ffdbUNII 70FD1KFU70

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410893053004 followed by a unit qualifier and the quantity

Package 10893-0530-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 18, 2024.

Indications (excerpt from the label)

Uses: Symptomatic treatment of mite infections.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)